Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,959,715 | $8,800,488 | $7,620,209 | $8,290,586 |
| - Cash | $178,350 | $263,958 | $74,126 | $32,895 |
| + Debt | $140,844 | $155,111 | $247,009 | $323,542 |
| Enterprise Value | $7,922,209 | $8,691,641 | $7,793,092 | $8,581,233 |
| Revenue | $2,431,287 | $2,264,417 | $2,134,963 | $2,139,261 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Gross Profit | $854,348 | $798,815 | $765,086 | $769,803 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| EBITDA | $464,294 | $414,340 | $393,435 | $411,233 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |
| Net Income | $301,999 | $272,509 | $249,624 | $268,550 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| % Growth | 10.9% | 8.5% | -1.9% | – |
| Operating Cash Flow | $417,497 | $330,299 | $309,886 | $308,597 |
| Capital Expenditures | -$49,531 | -$56,854 | -$57,325 | -$58,675 |
| Free Cash Flow | $367,966 | $273,445 | $252,561 | $249,922 |